PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
47.09
ESG score below 80% of ADAP's 62.74. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
27.98
Environmental score below 80% of ADAP's 50.00. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
55.14
Social score below 80% of ADAP's 78.41. Jim Chanos would check for potential social license and litigation risks.
58.16
Similar governance score to ADAP's 59.80. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.